Archives: Agenda

• Why FSP changes oversight: where control, accountability and risk shift
• Designing oversight: clear layers, decision rights and risk-based measures
• Turning findings into action: evidence, proportionate escalation and a closed loop

• Why FSP changes oversight: where control, accountability and risk shift
• Designing oversight: clear layers, decision rights and risk-based measures
• Turning findings into action: evidence, proportionate escalation and a closed loop

• Why recruitment forecasts and feasibility assessments across the DACH region continue to miss targets despite strong research infrastructure and healthcare systems
• How increasing study competition, protocol complexity, and limited patient availability are placing growing pressure on sites
• The operational challenges impacting recruitment and patient access across the region
• How sponsors, CROs, and sites can work together to create more realistic feasibility strategies and more sustainable approaches to patient recruitment and site engagement

Moderator: Karen Cheng, Patient Advocate, The Myositis Association (TMA)

Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple prizes or Amazon gift cards. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!

• Reducing development costs through leaner clinical strategies
• Navigating evolving regulatory expectations for biosimilars in Europe and globally
• Understanding how outsourcing models differ for biosimilar programs versus innovative therapies